Pacific Biosciences
PACB
PACB
227 hedge funds and large institutions have $1.03B invested in Pacific Biosciences in 2022 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 87 increasing their positions, 62 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
33% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 51
49% less capital invested
Capital invested by funds: $2B → $1.03B (-$971M)
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Holders
227
Holding in Top 10
1
Calls
$7.58M
Puts
$9.38M
Top Buyers
| 1 | +$24.5M | |
| 2 | +$18.5M | |
| 3 | +$11M | |
| 4 |
1WCM
12 West Capital Management
New York
|
+$8.51M |
| 5 |
BlackRock
New York
|
+$7.83M |
Top Sellers
| 1 | -$72.7M | |
| 2 | -$24.2M | |
| 3 | -$14.8M | |
| 4 |
Millennium Management
New York
|
-$10.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$8.54M |